期刊
CURRENT OPINION IN GENETICS & DEVELOPMENT
卷 48, 期 -, 页码 51-56出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.gde.2017.10.009
关键词
-
资金
- US National Institutes of Health [R01CA175486]
- Natural Scientific Foundation of China [81572777]
- NATIONAL CANCER INSTITUTE [P30CA016672, R01CA175486] Funding Source: NIH RePORTER
Adenosine-to-inosine (A-to-I) RNA editing is the most common type of post-transcriptional nucleotide modification in humans, which is catalyzed in ADAR enzymes. Recent genomic studies have revealed thousands of altered RNA editing events in various cancer tissues, leading to diverse functional consequences. A critical role of individual A-to-I RNA editing events in cancer has been reported. Here, we review the current state of our knowledge on key A-to-I RNA editing events in coding and non-coding regions for their roles in cancer development and discuss their potential clinical utility. A better understanding of A-to-I RNA editing and its oncogenic mechanisms may facilitate the development of novel cancer therapeutic strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据